Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
AxoGen, Inc. | AXGN | 2.75M | $126.95M |
Simulations Plus, Inc. | SLP | 2.79M | $51.13M |
NeuroPace, Inc. | NPCE | 2.86M | $45.46M |
Amylyx Pharmaceuticals, Inc. | AMLX | 3.02M | $54.3M |
Tandem Diabetes Care, Inc. | TNDM | 3.38M | $51.06M |
908 Devices Inc. | MASS | 6.28M | $54.66M |
SI-BONE, Inc. | SIBN | 8.13M | $132.65M |
NeoGenomics, Inc. | NEO | 12.28M | $179.16M |